Mycophenolate mofetil for drug-induced vanishing bile duct syndrome

doi:10.3748/wjg.v13.i45.6087

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 45

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2825)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series.

Item

Count

PDF

883

HTML

1785

Figures (1-3)

157

Sum=2825

Dec 7, 2007 (publication date) through Nov 14, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Dec 7, 2007; 13(45): 6087-6089
Published online Dec 7, 2007. doi: 10.3748/wjg.v13.i45.6087

Full Size Figure Download Figure

Figure 3 Three-year follow-up: liver enzymes and bilirubin during treatment with prednisone (white arrow), azathioprine/prednisone (grey arrow), and mycophenolate mofetil/prednisone (black arrow). Prednisone was stopped at wk 140 (dashed arrow). A: AST/ALT; B: alkaline phosphatase; C: bilirubin.

Citation: Jakab SS, West AB, Meighan DM, Jr RSB, Hale WB. Mycophenolate mofetil for drug-induced vanishing bile duct syndrome. World J Gastroenterol 2007; 13(45): 6087-6089
URL: https://www.wjgnet.com/1007-9327/full/v13/i45/6087.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i45.6087